FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Intercept Resubmits NDA for Liver Fibrosis Drug

[ Price : $8.95]

FDA accepts for review an Intercept Pharmaceuticals NDA resubmission for obeticholic acid for use in treating patients with pre-ci...

Medtronic Recalls Extended to More HeartWare Batteries

[ Price : $8.95]

Medtronic updates a 2022 recall of its HeartWare Ventricular Assist Device System batteries and is now requesting the return of 12...

Panel to Discuss Opioid Postmarketing Requirement

[ Price : $8.95]

FDA plans a 4/19 Anesthetic and Analgesic Drug Products Advisory Committee meeting to discuss a postmarketing requirement issued t...

FDA Debars Linda and Mark Godding

[ Price : $8.95]

Federal Register notices: FDA issues two orders debarring Linda Godding and Mark Godding for five years from importing or offering...

FDA Lifts Clinical Hold on Pompe Gene Therapy

[ Price : $8.95]

FDA lifts a clinical hold against Astellas Pharma and its FORTIS Ph1/2 clinical trial evaluating AT845, an adeno-associated virus ...

ICH Quality Risk Management Guide Adopted by FDA

[ Price : $8.95]

The International Conference on Harmonization posts a final guide entitled Quality Risk Management Q9 (R1), which has been adopted...

Conformity Assessment Program Information Collection

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Accreditation Scheme for Conformity As...

Guide on Developing Dog Heartworm Drugs

[ Price : $8.95]

The agency is seeking public comment on the guidance for 60 days.

Surmodics SurVeil PMA Not Approvable: FDA

[ Price : $8.95]

FDA says a Surmodics PMA for its SurVeil drug-coated balloon to treat peripheral artery disease is not currently approvable.

FDA Amends, Repeals Some Rad Health Regs

[ Price : $8.95]

FDA publishes a final rule amending and repealing some radiological health regulations.